Article · UK Corporate Tax & R&D

UK Merged RDEC 20% Seven-Step Calculation: Worked Example Under CTA 2009 Part 13

How the 20% above-the-line credit, 15.00% vs. 16.20% effective rates, and CTA 2009 s. 1042I seven-step discharge work in practice

For accounting periods beginning on or after 1 April 2024, Finance Act 2024 Schedule 1 replaced the legacy UK SME and RDEC regimes for most companies with a single unified Merged RDEC Scheme under CTA 2009 Part 13, Chapter 1A (sections 1042A to 1042N). The headline rate is 20% of qualifying R&D expenditure (s. 1042G), brought into account above the line as a taxable trading receipt (s. 1042H).

Effective Net Benefit Rates Across UK Corporation Tax Bands

Because Merged RDEC is taxable above the line (s. 1042H), the net cash or tax benefit depends on the company's Corporation Tax band or loss-making status:

Taxpayer ProfileTax / Step 2 RateNet Immediate Benefit
Profitable - Main CT Rate (> £250,000)25%15.00%
Profitable - Small Profits Rate (<= £50,000)19%16.20%
Profitable - Marginal Relief Band (£50,000 to £250,000)26.5%14.70%
Loss-Making or Small-Profits Step 2 (<= £50,000)19% (s. 1042K(5))16.20%

Crucially, CTA 2009 section 1042K(5) applies the 19% small profits rate at Step 2 for both loss-making companies and profitable companies within the £50,000 small profits limit, while section 1042K(2) caps the Step 2 notional tax deduction at max(0, Remaining After Step 1 - Gross RDEC x (1 - Step 2 Rate)) so real CT paid at Step 1 is never double-taxed. Moreover, Finance Act 2024 abolished subsidised expenditure restrictions across both Merged RDEC and ERIS.

Worked Example: Northbridge Photonics Ltd (Full Profit vs. Modest Pre-RDEC Loss)

Northbridge Photonics Ltd incurs £3,380,000 in gross R&D spend during FY2025. After the 65% unconnected subcontractor/EPW factor and excluding £200,000 paid to a cost-driven Indian subcontractor under section 1138A(4) (while retaining £104,000 for exempt German regulatory testing under s. 1138A(2)), qualifying R&D is £2,900,000, generating a 20% gross Merged RDEC of £580,000.

CTA 2009 s. 1042I Seven-Step WaterfallScenario A1 (£4,200,000 Profit)Scenario A2 (-£200,000 Loss)
Baseline CT Without RDEC (25%)£1,050,000£0
Post-RDEC Taxable Profit (+£580,000, s. 1042H)£4,780,000£380,000
Post-RDEC Gross CT Liability (25%)£1,195,000£95,000
Step 1: Current-Period CT Offset (s. 1042I)£580,000£95,000
Net CT Payable to HMRC£615,000£0
Step 2: Notional Tax Withheld (s. 1042K(2) at 25%, CF s. 1042L)£0£50,000
Step 3: PAYE/NIC Cap Restriction (Cap: £1,940,000)£0£0
Steps 4-6: Other CT / Group / Other HMRC£0£0
Step 7: Immediate Cash Refund£0£435,000
Immediate Benefit (CT Saved + Cash)£435,000 (15.00%)£435,000 (15.00%, +£50,000 CF)

Step 2 (s. 1042L) vs. Step 3 (s. 1042J) Carry-Forward Pools

Never confuse Step 2 and Step 3 carry-forwards. Northbridge Scenario A2's £50,000 Step 2 pool (s. 1042L) can only offset future Corporation Tax (or be surrendered immediately to a 75% UK group company under s. 1042N) and can never become cash. By contrast, a Step 3 PAYE/NIC cap carry-forward (s. 1042J(2)) rolls into Step 1 of the next accounting period (excluded from a second Step 2 charge under s. 1042K(9)) and can convert into Step 7 cash once PAYE/NIC headroom is restored.

Free Excel Calculator & Complete Handbook

Run your own UK R&D figures through the live 7-step Merged RDEC, ERIS 30% intensity, and PAYE/NIC cap model in UK_RD_Merged_RDEC_ERIS_Calculator.xlsx, or read the complete 15-chapter practitioner reference in The UK R&D Tax Relief Handbook.

Get the free Excel calculator → View the handbook →

Further reading

Next: UK ERIS 30% R&D Intensity Test and 14.5% Payable Credit

Also read: UK R&D Contracted-Out Rules, Overseas Restrictions, and PAYE/NIC Cap

Related UK corporate tax handbooks: UK Corporate Interest Restriction · UK VAT Partial Exemption · OECD Pillar Two